The spread of antimicrobial resistance (AMR) is threatening modern medicine, despite progress in tackling drug-resistant bacteria, senior World Health Organization (WHO) officials said on Monday.
Countries have stepped up efforts to address AMR, but progress in prevention, diagnosis and the appropriate use of antibiotics remains too slow to meet global targets, WHO officials warned.
Bacteria have long evolved resistance to medicines designed to kill them. Widespread antibiotic use in human health, animal husbandry and food production has accelerated the problem, making AMR one of the leading causes of deaths from infectious diseases worldwide.
“Antimicrobial resistance is widespread and threatening the future of modern medicine,” said Jean-Pierre Nyemazi, the WHO’s interim head of antimicrobial resistance.
“Unlike COVID-19, which was very visible, drug-resistant infections have been taking people’s lives for years without us noticing and raising the alarm as we should,” Nyemazi said.
In 2021, AMR was directly responsible for more than one million deaths and linked to about 4.7 million others, the agency said.
A WHO survey of 183 countries found that nearly nine in 10 had a national action plan to tackle AMR, up from about four in 10 in 2017. However, only 42 countries—fewer than one in five—said their plans were funded, implemented and monitored, said Pravasha Prakash, an AMR technical officer at the agency.
“Countries are moving forward at every step, but progress still needs to be accelerated to reach the 2030 targets,” she said.
Gaps in Diagnostic Access
Access to diagnostic testing remains a major weakness. Only 36 per cent of countries had a national reference laboratory capable of testing for resistance in all the bacteria and fungi monitored by the WHO—well below the 2030 target of 80 per cent.
“Without testing, clinicians must treat patients without knowing the cause of infection or which antibiotic will work,” said Sylvia Bertagnolo, the WHO’s head of AMR surveillance.
The latest global surveillance data show that in 2023, one in every six laboratory-confirmed bacterial infections reported to the WHO was resistant to the antibiotics used to treat it.
The WHO has announced two new tools to help countries strengthen their diagnostic capacity. The first sets out which tests should be available at each level of the healthcare system, from primary care centres to referral hospitals.
The second compiles 73 laboratory procedures, covering everything from sample collection to pathogen identification and antibiotic susceptibility testing.
The WHO estimates that AMR could cause about 39 million deaths between now and 2050.
The agency said existing antibiotics must be used more appropriately, as the development of new treatments is failing to keep pace with rising resistance.
Infection prevention, vaccination, better access to water and sanitation, and the appropriate use of antimicrobials are key measures to combat AMR, it added.

